Fintech PR
Road safety: Data show improvements in 2018 but further concrete and swift actions are needed
Reading Time: 3 minutes
Fewer people died on European roads last year but more efforts are needed to make a big leap forward, according to new, preliminary figures on road fatalities for 2018 published today by the European Commission.
In 2018, there were around 25 100 fatalities in road accidents in the EU 28. This is a decrease of 21% compared to 2010, and 1% compared to 2017. With an average of 49road deaths per one million inhabitants, this confirms that European roads are by far the safest in the world. But it also shows we are off track to reach our target of halving the number of road deaths by 2020. This underlines the need for swift action by Member States and the entire road safety community to deliver on the EU’s strategic road safety action plan, published in May 2018 as part of the Juncker Commission’s ‘Europe on the Move‘ package, which set out specific actions envisaged under the current Commission mandate.
Commissioner for Transport Violeta Bulc said: “While I of course welcome any reduction in road traffic fatality figures, even a single road death is unacceptable. We have been assertive and ambitious in tackling road safety, adopting a strategic action plan, concrete actions on vehicle and infrastructure safety, and a policy framework for the next decade. As we continue to work towards ‘Vision Zero’ – zero road deaths by 2050, we are committed to working with all Member States, as well as the Parliament and road safety community, to provide a level of safety that EU citizens demand and deserve.“
The Commission has already delivered concrete measures on vehicles and infrastructure safety, and both were agreed upon by the Parliament and Council in early 2019. For infrastructure, risk mapping will be carried out for all motorways and for primary roads, and vulnerable road-users will have to be systematically taken into account in all safety assessments, audits and inspections. For vehicles, a number of safety features will be included in all new vehicles, such as Intelligent Speed Assistance to help drivers keep within the speed limit, and other proven new technologies such as Automated Emergency Braking and Lane Keeping Assistance.
For the majority of Member States, the road fatality rate was below 60 deaths per million inhabitants in 2018.
The EU countries with the best road safety results in 2018 were the United Kingdom (28 deaths/million inhabitants), Denmark (30/million), Ireland (31/million), and Sweden (32/million). The countries with a higher-than-average decrease in road deaths from 2017 to 2018 were Slovenia (-13%), Lithuania (-11%), Bulgaria (-9%) and Slovakia and Cyprus (both -8%).
Only two EU Member States recorded a fatality rate higher than 80 deaths per million inhabitants, against 7 in 2010. The countries with the highest fatality rate were Romania (96/million), Bulgaria (88/million), Latvia (78/million) and Croatia (77/million).
A large number of vulnerable road users were affected: pedestrians, cyclists, motorcyclists and the elderly, particularly in urban areas. With demographic changes and the ongoing trend towards active and sustainable mobility, these groups are expected to represent a higher proportion of road users in the future, and will require particular attention.
In addition to fatalities, the EU’s focus is also on the seriously injured: it is estimated that, for every road death, five more people were seriously injured on EU roads last year (around 135,000).
Next steps
In its road safety policy framework for 2021-2030 and strategic action plan on road safety, both published in May 2018 as part of the ‘Europe on the Move’ package, the Commission confirms the EU’s long-term goal of moving close to zero fatalities and serious injuries in road transport by 2050. The new interim targets, responding to the 2017 Valletta Declaration by transport ministers are to cut the number of road deaths by 50% between 2020 and 2030, and to halve the number of serious injuries in the same period.
For more information
MEMO: 2018 road safety statistics: What is behind the figures?
Commission’s road safety work and EU road safety statistics
Road deaths per million inhabitants – preliminary country by country statistics for 2018[1]
| 2010 | 2017 | 2018 | 2017-2018 | 2010-2018 | |
| Belgium | 77 | 54 | 52 | -4% | -30% |
| Bulgaria | 105 | 96 | 88 | -9% | -20% |
| Czech Republic | 77 | 55 | 62 | 14% | -18% |
| Denmark | 46 | 30 | 30 | 0% | -31% |
| Germany | 45 | 39 | 39 | 3% | -10% |
| Estonia | 59 | 36 | 51 | 40% | -15% |
| Ireland | 47 | 33 | 31 | -5% | -30% |
| Greece | 113 | 68 | 64 | -6% | -45% |
| Spain | 53 | 39 | 39 | -1% | -27% |
| France | 64 | 51 | 48 | -5% | -18% |
| Croatia | 99 | 80 | 77 | -4% | -26% |
| Italy | 70 | 56 | 55 | -2% | -20% |
| Cyprus | 73 | 62 | 57 | -8% | -18% |
| Latvia | 103 | 70 | 78 | 10% | -31% |
| Lithuania | 95 | 67 | 61 | -11% | -43% |
| Luxembourg | 64 | 42 | 60 | 44% | 13% |
| Hungary | 74 | 64 | 64 | 1% | -15% |
| Malta | 31 | 41 | 38 | -5% | 38% |
| Netherlands[2] | 32 | 31 | – | – | – |
| Austria | 66 | 47 | 45 | -3% | -28% |
| Poland | 103 | 75 | 76 | 2% | -26% |
| Portugal | 80 | 58 | 59 | 1% | -35% |
| Romania | 117 | 99 | 96 | -4% | -21% |
| Slovenia | 67 | 50 | 44 | -13% | -34% |
| Slovakia | 65 | 51 | 46 | -8% | -28% |
| Finland | 51 | 43 | 43 | -1% | -13% |
| Sweden | 28 | 25 | 32 | 28% | 22% |
| United Kingdom[3] | 30 | 28 | 28 | -2% | -4% |
| EU 28 | 63 | 49 | 49 | -1% | -21% |
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Fintech6 days agoHow to identify authenticity in crypto influencer channels
-
Latest News6 days ago
HSBC-backed fintech Monese is considering splitting its operations as it grapples with increasing losses.
-
Latest News5 days ago
EverBank has announced a groundbreaking partnership with Finzly, poised to revolutionize payment processing.
-
Latest News5 days ago
FinTech leaders express caution regarding the promises made in #Budget2024 concerning open banking, stating that the “devil is in the details.”
-
Latest News5 days ago
Gotion High-tech’s operating profit up 391% in 2023, nearly RMB 2.8 billion invested in R&D for the year
-
Latest News5 days ago
Aurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
-
Latest News6 days ago
Wells Fargo, a leading financial institution, is set to revolutionize its trade finance operations by incorporating artificial intelligence (AI) technology through its collaboration with TradeSun.
-
Latest News5 days ago
Latvian Fintech inGain Raises €650,000 for No-Code SaaS Loan Management System